Table of Content

1 Relevant Concepts of Recombinant Human Endostatin
1.1 Indications for Recombinant Human Endostatin
1.2 Development of Recombinant Human Endostatin in China
1.3 Patents and Government Approval on Recombinant Human Endostatin in China


2 Sales of Recombinant Human Endostatin in China, 2013-2017
2.1 Sales Value
2.2 Sales volume
2.3 Sales of Recombinant Human Endostatin by Dosage Form in China, 2013-2017


3 Analysis on Major Manufacturers of Recombinant Human Endostatin in China, 2013-2017
3.1 Analysis on Market Share of Major Manufacturers of Recombinant Human Endostatin
3.2 Yantai Medgenn Co., Ltd.


4 Prices of Recombinant Human Endostatin in China, 2017-2018
4.1 Yantai Medgenn Co., Ltd. (Endostar)
4.2 Analysis on Potential Competitors


5 Prospect of China’s Recombinant Human Endostatin Market, 2019-2023
5.1 Factors Influencing Development of China’s Recombinant Human Endostatin Market
5.1.1 Driving Forces and Market Opportunities
5.1.2 Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trends



Selected Charts
Chart Sales of Recombinant Human Endostatin in China, 2013-2017
Chart Sales Value of Recombinant Human Endostatin in Parts of China, 2013-2017
Chart Sales Volume of Recombinant Human Endostatin in China, 2013-2017
Chart Sales Volume of Recombinant Human Endostatin in Parts of China, 2013-2017
Chart Sales Value of Recombinant Human Endostatin Injection in China, 2013-2017
Chart Sales Volume of Recombinant Human Endostatin Injection in China, 2013-2017
Chart Sales Value of Recombinant Human Endostatin by Yantai Medgenn Co., Ltd., 2013-2017
Chart Prices of Recombinant Human Endostatin by Yantai Medgenn Co., Ltd. in Parts of China, 2017-2018
Chart Patents on Recombinant Human Endostatin in China
Chart Government Approval on Recombinant Human Endostatin in China
Chart Forecast on Sales Value of Recombinant Human Endostatin in China, 2019-2023